Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety & Efficacy of BGP-15 in Type 2 Diabetes
NCT01069965Phase 2Terminated
- Sponsor
- N-Gene Research & Development
- Start
- Oct 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of BGP-15 in type 2 diabetes mellitus (T2DM), sponsored by N-Gene Research & Development. Started Oct 2010; status: terminated.
02
Drugs
BGP-15
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01069965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01069965.